Shopping Cart
Remove All
Your shopping cart is currently empty
Prasinezumab
😃Good
Catalog No. T76889Cas No. 1960462-19-4
Alias RO7046015, RO 7046015, RG7935, RG 7935, PRX002, PRX 002
Prasinezumab is a monoclonal antibody that selectively binds aggregated α-synuclein. Prasinezumab is under investigation as a disease-modifying therapeutic candidate for early-stage Parkinson’s disease, where it is being evaluated for its ability to interfere with pathogenic α-synuclein aggregation and progression of neurodegeneration.
Prasinezumab
Prasinezumab
😃Good
Purity: 95%
Catalog No. T76889Alias RO7046015, RO 7046015, RG7935, RG 7935, PRX002, PRX 002Cas No. 1960462-19-4
Prasinezumab is a monoclonal antibody that selectively binds aggregated α-synuclein. Prasinezumab is under investigation as a disease-modifying therapeutic candidate for early-stage Parkinson’s disease, where it is being evaluated for its ability to interfere with pathogenic α-synuclein aggregation and progression of neurodegeneration.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $373 | - | In Stock | |
| 5 mg | $1,120 | - | In Stock | |
| 10 mg | $1,790 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:97.5% (SDS-PAGE); 96.0% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Prasinezumab is a monoclonal antibody that selectively binds aggregated α-synuclein. Prasinezumab is under investigation as a disease-modifying therapeutic candidate for early-stage Parkinson’s disease, where it is being evaluated for its ability to interfere with pathogenic α-synuclein aggregation and progression of neurodegeneration. |
| Synonyms | RO7046015, RO 7046015, RG7935, RG 7935, PRX002, PRX 002 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | Alpha-synuclein |
| Molecular Weight | 145.25 kDa |
| Cas No. | 1960462-19-4 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Prasinezumab | purchase Prasinezumab | Prasinezumab cost | order Prasinezumab | Prasinezumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.